Primary samples bring added value to your projects and provide results remarkably closer to the real scenario in comparison to regular commercial cell lines.
Specific inclusion/exclusion criteria and clinical data required for your research are always up for discussion. Feasibility and collection timelines will be carefully evaluated by our team, together with our medical advisors and collaborators.
Vivia Biotech access to primary samples is supported by an extensive collaboration with >100 national and international hospitals, health centers and biobanks, and with guarantee that sample collection is performed in accordance with GCP guidelines and after Patient Declaration of Consent.